Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Examining Survivin levels may help understand premature greying of hair.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Proper tissue repair in adult skin requires specific histone hypomethylation.

Serine is vital for hair follicle stem cells to balance hair growth and skin repair.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Dermal fibroblasts have adjustable roles in wound healing, with specific cells promoting regeneration or scar formation.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

MPZL3 protein affects hair growth cycles and could help manage hair loss.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

ILC1-like cells can independently cause alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Hair follicle stem cells can help treat eye surface issues by becoming corneal cells.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

The scalp's microorganisms significantly affect hair health and disease.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

PTEN helps control the number and health of skin stem cells by working with the protein BMAL1.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Dandruff is linked to changes in the immune system of hair follicles and skin.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.